Trial Profile
Long term efficacy study of imatinib in patients with chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2017
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 01 Aug 2017 Results of long term outcomes (n=559) of 3 studies (CML021, CML022, CML023) published in the American Journal of Hematology.
- 21 Jan 2016 New trial record
- 08 Dec 2015 Long term analysis of 3 trials (n=559) presented at the 57th Annual Meeting and Exposition of the American Society of Hematology